within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BH04_Alogliptin;

model Alogliptin
  extends Pharmacolibrary.Drugs.ATC.A.A10BH04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BH04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Alogliptin is an oral antihyperglycemic agent, classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor, used in the management of type 2 diabetes mellitus to improve glycemic control. It is approved for adult use and is available as a prescription medication in several countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after single oral dose administration.</p><h4>References</h4><ol><li><p>Karim, A, et al., &amp; Mekki, Q (2010). Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects. <i>International journal of clinical pharmacology and therapeutics</i> 48(1) 46–58. DOI:<a href=&quot;https://doi.org/10.5414/cpp48046&quot;>10.5414/cpp48046</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20040339/&quot;>https://pubmed.ncbi.nlm.nih.gov/20040339</a></p></li><li><p>Dudkowski, C, et al., &amp; Xie, J (2017). The pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus. <i>European journal of clinical pharmacology</i> 73(3) 279–288. DOI:<a href=&quot;https://doi.org/10.1007/s00228-016-2175-1&quot;>10.1007/s00228-016-2175-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27999883/&quot;>https://pubmed.ncbi.nlm.nih.gov/27999883</a></p></li><li><p>Christopher, R, et al., &amp; Karim, A (2008). Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects. <i>Clinical therapeutics</i> 30(3) 513–527. DOI:<a href=&quot;https://doi.org/10.1016/j.clinthera.2008.03.005&quot;>10.1016/j.clinthera.2008.03.005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18405789/&quot;>https://pubmed.ncbi.nlm.nih.gov/18405789</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Alogliptin;
